Research programme: glucokinase stimulants - Array BioPharma

Drug Profile

Research programme: glucokinase stimulants - Array BioPharma

Alternative Names: ARRY-588

Latest Information Update: 27 Aug 2013

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Array BioPharma
  • Class Small molecules
  • Mechanism of Action Glucokinase stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Preclinical Type 2 diabetes mellitus

Most Recent Events

  • 07 Aug 2013 This programme is no longer licensed to Amgen worldwide
  • 16 Dec 2009 Array BioPharma grants Amgen exclusive worldwide rights to its small molecule glucokinase stimulant programme
  • 10 Jun 2008 Preclinical trials in Type-2 diabetes mellitus in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top